Blog

Clyra Medical Technologies, Inc. has successfully concluded a financing from Sanatio Capital LLC for $750,000 in equity and a forward commitment to provide a $5,000,000 operating line of credit, to support the FDA approval and commercial launch of Clyra’s advanced wound care products. Clyra Medical Technologies holds the exclusive license to commercialize BioLargo’s technology in…

Milestones Reached in Advanced Wound Care

Clyra Medical Technologies has accomplished a number of significant achievements in its march toward development of advanced wound care products. Preliminary formulations of our antimicrobial “hydrogel” and “liquid wound cleanser” products have passed rigorous third party laboratory testing validating both efficacy and safety. Independent testing has verified both rapid and effective control against a host…

MENU